Risk / Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 - Developments in Cardiovascular Medicine - Symposium on New Drugs and Devices - Books - Kluwer Academic Publishers - 9780792302940 - June 30, 1989
In case cover and title do not match, the title is correct

Risk / Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 - Developments in Cardiovascular Medicine

Symposium on New Drugs and Devices

Price
A$ 371.49

Ordered from remote warehouse

Expected delivery Mar 20 - Apr 2

Our customers say:

14-day return policy in accordance with European consumer protection law
Top ranking on Trustpilot
Add to your iMusic wish list

Risk / Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 - Developments in Cardiovascular Medicine

Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 and 28, 1988

298 pages, biography

Media Books     Hardcover Book   (Book with hard spine and cover)
Released June 30, 1989
ISBN13 9780792302940
Publishers Kluwer Academic Publishers
Pages 298
Dimensions 156 × 234 × 19 mm   ·   648 g
Editor Moore, E. Neil
Editor Morganroth, Joel

See all of Symposium on New Drugs and Devices ( e.g. Hardcover Book )